Prognosia Breast, an AI-driven mammography tool, receives FDA Breakthrough Device status for improved five-year breast cancer risk prediction.
Key Details
- 1FDA granted Breakthrough Device designation to Prognosia Breast, an AI mammography analysis tool.
- 2Developed by Washington University School of Medicine experts.
- 3Tool predicts five-year breast cancer risk from mammogram findings.
- 4Claims to be twice as accurate as current risk assessment methods.
- 5Aims to inform decisions on supplemental imaging and genetic testing.
Why It Matters
FDA's recognition accelerates the path for advanced AI-enabled risk assessment in breast cancer screening. Improved prediction can enhance early intervention and personalisation, potentially reducing morbidity and mortality.
Source
Health Imaging
Related News
•AuntMinnie
AI Model Synthesizes Early-Stage PDAC CTs for Improved Detection
Researchers created AI models to generate synthetic early-stage PDAC CT scans, boosting early tumor detection sensitivity.
•AuntMinnie
AI Model Accurately Detects Pediatric Physeal Fractures on X-Ray
A deep learning model accurately identifies hard-to-detect physeal fractures in children's wrist x-rays.
•Radiology Business
Mallinckrodt Institute Launches Center for AI Imaging Innovation
Mallinckrodt Institute of Radiology is establishing a center to advance AI-based imaging technologies in collaboration with other Washington University units.